Causal Relationship: Development of Gastric Epithelial Polyp in Korea

Hyuk Lee

doi:10.4166/kjg.2019.74.1.1

Journal List > Korean J Gastroenterol > v.74(1) > 1129970

Go to TopGo to Top Go to BottomGo to Bottom

See the article "".

TOOLS

Lee: Causal Relationship: Development of Gastric Epithelial Polyp in Korea

Editorial

The Korean Journal of Gastroenterology 2019; 74(1): 1-3.

Published online: 26 July 2019

DOI: https://doi.org/10.4166/kjg.2019.74.1.1

Causal Relationship: Development of Gastric Epithelial Polyp in Korea

Hyuk Lee

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Correspondence to: Hyuk Lee, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea. Tel: +82-2-3410-3409, Fax: +82-2-3410-6983, leehyuk@skku.edu

Korean Society of Gastroenterology

(open-access):

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Notes

^{Financial support} None.

^{Conflict of interest} None.

References

1. Lee SW. Diagnosis and management of gastric polyps. Korean J Med. 2016; 90:307–312.

2. Zelter A, Fernández JL, Bilder C, et al. Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies. Dig Dis Sci. 2011; 56:1743–1748.

3. Cao H, Wang B, Zhang Z, Zhang H, Qu R. Distribution trends of gastric polyps: an endoscopy database analysis of 24 121 northern Chinese patients. J Gastroenterol Hepatol. 2012; 27:1175–1180.

4. Markowski AR, Markowska A, Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps. World J Gastroenterol. 2016; 22:8883–8891.

5. Ohkusa T, Takashimizu I, Fujiki K, et al. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med. 1998; 129:712–715.

6. Goddard AF, Badreldin R, Pritchard DM, Walker MM, Warren B. British Society of Gastroenterology. The management of gastric polyps. Gut. 2010; 59:1270–1276.

7. Martin FC, Chenevix-Trench G, Yeomans ND. Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors. Aliment Pharmacol Ther. 2016; 44:915–925.

8. Watanabe N, Seno H, Nakajima T, et al. Regression of fundic gland polyps following acquisition of Helicobacter pylori. Gut. 2002; 51:742–745.

9. Jalving M, Koornstra JJ, Wesseling J, Boezen HM, De Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006; 24:1341–1348.

10. Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998; 110:615–621.

11. Kim JS, Chae HS, Kim HK, et al. Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole. Korean J Gastroenterol. 2008; 51:305–308.

12. Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016; 14:1706–1719.

13. Jeong CY, Kim N, Lee HS, et al. Risk factors of multiple gastric polyps according to the histologic classification: prospective observational cohort study. Korean J Gastroenterol. 2019; 74:17–29.

TOOLS

ORCID iDs: Hyuk Lee
https://orcid.org/0000-0003-4271-7205
Similar articles